Baidu
map

Immune Checkpoint Blockade in Cancer Immunotherapy: Mechanisms, Clinical Outcomes, and Safety Profiles of PD-1/PD-L1 Inhibitors

Yan, Y; Zhang, L; Zuo, Y; Qian, HY; Liu, C

Zhang, L (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China.; Zhang, L (corresponding author), Univ South Carolina, Coll Pharm, Columbia, SC 29208 USA.; Liu, C (corresponding author), Univ Rhode Isl, Coll Pharm, Kingston, RI 02881 USA.

ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2020; 68 (6):

Abstract

Programmed cell death protein 1 (PD-1) and its ligand PD-L1 are critical for the regulation of T cell exhaustion and activity suppression. Tumor cells......

Full Text Link


Baidu
map
Baidu
map
Baidu
map